In a significant achievement for Switzerland-based CARBOGEN AMCIS, a leading name in pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing, the company announced its successful clearance of the Brazilian Regulatory Authority Agency (ANVISA) routine inspection at its Shanghai facility. Conducted from November 6 to 10, 2023, the five-day inspection concluded with the granting of […]
Supriya Lifescience Limited, a global leader in the manufacturing of Active Pharmaceutical Ingredients (APIs), has recently marked a significant milestone in its commitment to high-quality standards. The company proudly announced that its manufacturing site in Lote Parshuram has received Good Manufacturing Practice (GMP) certification from the Regulatory Authority of Brazil, ANVISA. This achievement highlights Supriya […]
Morinaga Milk Industry Co., Ltd., a Japanese dairy product leader, received approval from the Brazilian Health Regulatory Agency (ANVISA) for its Bifidobacterium longum BB536. The approval, effective July 27, 2023, enables the use of the probiotic strain in dietary supplements and conventional foods in Brazil. The strain has now been added to ANVISA’s list of […]
Caplin Point Laboratories said that its subsidiary — Caplin Steriles has secured approval from Agência Nacional de Vigilância Sanitária (ANVISA), the Brazilian national health surveillance agency, for its sterile injectable manufacturing plant in Tamil Nadu (TN). The approval from ANVISA enables Caplin Steriles to register and market its products in Brazil, which is considered to […]
